Recovery from the Middle East Respiratory Syndrome is Associated with Antibody and T Cell Responses()

The Middle East Respiratory Syndrome-coronavirus (MERS-CoV) causes a highly lethal pneumonia. MERS was recently identified as a candidate for vaccine development but most efforts focus on antibody responses, which are often transient after CoV infections. CoV-specific T cells are generally long-live...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Immunol
Main Authors: Zhao, Jingxian, Alshukairi, Abeer N., Baharoon, Salim A., Ahmed, Waleed A., Bokhari, Ahmad A., Nehdi, Atef M., Layqah, Laila A., Alghamdi, Mohammed G., Al Gethamy, Manal M., Dada, Ashraf M., Khalid, Imran, Boujelal, Mohamad, Al Johani, Sameera M., Vogel, Leatrice, Subbarao, Kanta, Mangalam, Ashutosh, Wu, Chaorong, Eyck, Patrick Ten, Perlman, Stanley, Zhao, Jincun
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576145/
https://ncbi.nlm.nih.gov/pubmed/28778905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.aan5393
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares